Pulike Biological Engineering (SHSE:603566) Other Current Payables: ¥186 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:603566 Pulike Biological Engineering Inc SHSE:603566
66 GF Score
Price ¥10.36
GF Value ¥14.51
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is Pulike Biological Engineering Other Current Payables?

Pulike Biological Engineering SHSE:603566 -0.67% 66 Other Current Payables is ¥186 Mil as of Mar. 2026. GuruFocus rates SHSE:603566 with a GF Score™ of 66/100 and a GF Value™ of ¥14.51 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Pulike Biological Engineering's Other Current Payables for the quarter that ended in Mar. 2026 was ¥186 Mil.

Pulike Biological Engineering's quarterly Other Current Payables declined from Sep. 2025 (¥297 Mil) to Dec. 2025 (¥217 Mil) and declined from Dec. 2025 (¥217 Mil) to Mar. 2026 (¥186 Mil).

Pulike Biological Engineering's annual Other Current Payables declined from Dec. 2023 (¥324 Mil) to Dec. 2024 (¥262 Mil) and declined from Dec. 2024 (¥262 Mil) to Dec. 2025 (¥217 Mil).

Pulike Biological Engineering Other Current Payables Related Terms

Pulike Biological Engineering Other Current Payables Historical Data

* Premium members only.

The historical data trend for Pulike Biological Engineering's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pulike Biological Engineering Other Current Payables Chart

Pulike Biological Engineering Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 265.30 336.16 324.29 262.14 216.64

Pulike Biological Engineering Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 222.20 238.07 296.84 216.64 185.68
SHSE:603566
66GF Score
Pulike Biological Engineering Inc SHSE:603566
Other Current Payables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pulike Biological Engineering Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of ¥186 Mil mean?
Pulike Biological Engineering (SHSE:603566) has a Other Current Payables of ¥186 Mil as of Mar. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pulike Biological Engineering and its competitors.
Is Pulike Biological Engineering's Other Current Payables too high?
Pulike Biological Engineering's current Other Current Payables is ¥186 Mil. Overall, Pulike Biological Engineering has a GF Score™ of 66/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pulike Biological Engineering's Other Current Payables compare to VRTX and REGN?
Pulike Biological Engineering's Other Current Payables of ¥186 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Biotechnology company?
A good Other Current Payables depends on the Biotechnology industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on Pulike Biological Engineering and its competitors. Pulike Biological Engineering's current Other Current Payables is ¥186 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pulike Biological Engineering stock overvalued right now?
Based on GuruFocus' analysis, Pulike Biological Engineering (SHSE:603566) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥14.51, compared to a current price of ¥10.36 — trading 28.6% below its estimated fair value. The current Other Current Payables is ¥186 Mil. Pulike Biological Engineering's overall GF Score™ is 66/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For Pulike Biological Engineering (SHSE:603566), the current Other Current Payables is ¥186 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pulike Biological Engineering (SHSE:603566) Overvalued in 2026?

Based on GuruFocus' analysis, Pulike Biological Engineering stock appears to be undervalued. The current stock price of ¥10.36 is trading 28.6% below its estimated GF Value™ of ¥14.51. GuruFocus considers Pulike Biological Engineering to be Modestly Undervalued.

Key valuation signals for SHSE:603566:

  • Other Current Payables: ¥186 Mil
  • GF Value™: ¥14.51 vs. price of ¥10.36 (28.6% below fair value)
  • GF Score™: 66/100 with 5 warning signs

No single metric tells the full story. See the SHSE:603566 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pulike Biological Engineering Business Description

Address 15th New governance, Henan Province, Luoyang, CHN, 471000
Pulike Biological Engineering Inc is engaged in the research and development and production and operation of veterinary drugs.
66GF Score

Get the complete analysis for SHSE:603566

Other Current Payables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥10.36
Price
¥14.51
GF Value